echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Announcement on the Draft Standard of Nitrogen and Calcium Carbonate Pharmaceutical Excipients

    Announcement on the Draft Standard of Nitrogen and Calcium Carbonate Pharmaceutical Excipients

    • Last Update: 2022-08-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The State Pharmacopoeia Committeeplans to formulate standards for pharmaceutical excipients of nitrogen and calcium carbona.


    Contact: Chen Lei, Kang Xiaobo

    Tel: 010-67079566, 67079620

    Email: 475@c.


    Mailing address: Office of the State Pharmacopoeia Committee, Building 11, Fahuananli, Dongcheng District, Beijing

    Postcode: 100061

    National Pharmacopoeia Commission

    July 07, 2022

    Attachment 1: Public Draft Standard of Nitrogen Pharmaceutical Excipien.


    Attachment 2: Public Draft of Standard Draft of Calcium Carbonate Medicinal Excipien.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.